Company intelligence

RZLT

Rezolute, Inc. · NASDAQ · Healthcare

Price$4.01+3.35% · +$0.13

Market cap387.86MEquity value

P / E-5.3Trailing ratio

Volume919.23KLatest session

Market data

RZLT price chart

TradingView

Related signals

1 min delayed

Browse public RZLT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

RZLTDec 12, 2025

Rezolute Faces Major Stock Plunge and Fraud Investigations Following Phase 3 Trial Failures

RZLT's stock dropped nearly 90% after Phase 3 trial failure. The trial did not meet the primary endpoint for ersodetug. Securities law investigations may ensue following this announcement. Potential investor actions could arise due to the trial's outcome. Phase 3 failure raises significant concerns for RZLT's future.

View signal analysis

Research